Home
  >  
Section 40
  >  
Chapter 39,919

Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer

Satomi, T.; Inoue, S.; Fujita, T.; Ogawa, S.; Honda, H.; Hayashi, M.

Gan no Rinsho. Japan Journal of Cancer Clinics 35(4): 512-515

1989


ISSN/ISBN: 0021-4949
PMID: 2541269
Accession: 039918672

Download citation:  
Text
  |  
BibTeX
  |  
RIS

OK-432 has been injected endoscopically into 4 patients with an unresectable esophageal or gastric cancer. Three months after the initial injection, a remarkable improvement in the symptoms and a reduction of the tumor size was recognized in all 4 patients. This study indicates that an OK-432 injection provides considerable benefits to patients with an advanced esophageal or gastric cancer.

PDF emailed within 1 workday: $29.90